Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Shital Patel

HIV/AIDS Medicine · BCM

View

Dr. Monica Gandhi

HIV/AIDS Medicine · UCSF

View

Dr. Ashwin Balagopal

HIV/AIDS Medicine · Johns Hopkins

View

Dr. Ofole Mgbako

HIV/AIDS Medicine · NYU Langone

View

Dr. Joshua Barocas

HIV/AIDS Medicine · CU Anschutz Medical Campus

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Keith Kaye

General ID · RU

View

Dr. Helen Boucher

Transplant/Immunocompromised States · Tufts

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RLDr. Raphael J. Landovitz
    Leading Voice

    Dr. Raphael J. Landovitz

    Infectious Disease · HIV & AIDS Medicine
    University of California, Los Angeles
    raphaell
    Los Angeles, CA, USA
    Oct 27, 2026Journal Article

    Mixed Models, Not Mixed Messaging: Reply to Haddad, et al.

    ​
    ​

    Written by 2 Roon authors & 2 others

    Via Clinical Infectious Diseases
    Jan 13, 2026Journal Article

    Emergence of a novel genotype of extensively drug-resistant Shigella sonnei carrying blaDHA-1 in diverse patient populations, Los Angeles, 2024-2025.

    ​

    Written by 1 Roon author & 5 others

    Via Antimicrobial Stewardship & Healthcare Epidemiology

    Research

    Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study

    2026

    Via Lancet HIV

    Research

    Protecting Preexposure Prophylaxis: The Perils of Laboratory Testing Ignored

    2026

    Via AIDS

    Feb 26, 2026Original Article

    Tecovirimat for the Treatment of Mpox

    ​
    ​

    Written by 2 Roon authors & 25 others

    Via The New England Journal of Medicine

    Research

    Use of DNA profiling to resolve HIV status in a person using injectable cabotegravir for HIV pre-exposure prophylaxis

    2026

    Via Journal of Clinical Pathology

    Feb 25, 2026Journal Article

    Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083.

    ​

    Written by 1 Roon author & 17 others

    Via Clinical Infectious Diseases

    Research

    Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083

    2026

    Via The Journal of Infectious Diseases

    Feb 26, 2026Original Article

    Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges

    ​

    Written by 1 Roon author & 35 others

    Via The New England Journal of Medicine
    Sep 2, 2026Journal Article

    Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.

    ​

    Written by 1 Roon author & 36 others

    Via Clinical Infectious Diseases
    Jul 23, 2026Journal Article

    Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve.

    ​
    ​

    Written by 2 Roon authors & 1 other

    Via Clinical Infectious Diseases

    Research

    Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review and meta-analysis

    2026

    Via PLOS Medicine

    Oct 28, 2026Journal Article

    Prospective HIV RNA Screening With Long-acting Cabotegravir Pre-exposure Prophylaxis in HPTN 083.

    ​

    Written by 1 Roon author & 23 others

    Via Clinical Infectious Diseases
    May 14, 2026Correspondence

    Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges

    Via The New England Journal of Medicine

    Research

    PrEP as a "Hidden Message": The Impact of Partner Dynamics on Oral PrEP Adherence Among Cisgender Women in Serodiscordant Relationships

    2026

    Via AIDS and Behavior